United States · FDA National Drug Code directory
tizanidine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1112_a619e873-810c-450b-bd4e-de0541ed3e63
- Product NDC
- 70710-1112
- Form
- CAPSULE
- Composition / generic term
- tizanidine hydrochloride
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170427
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (70710-1112-4) / 10 CAPSULE in 1 BLISTER PACK · 70710-1112-4
- 500 CAPSULE in 1 BOTTLE (70710-1112-5) · 70710-1112-5
- 150 CAPSULE in 1 BOTTLE (70710-1112-8) · 70710-1112-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →